Bolt Biotherapeutics (BOLT) Receivables - Other (2023 - 2025)
Bolt Biotherapeutics (BOLT) has disclosed Receivables - Other for 3 consecutive years, with $973000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 16.48% to $973000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $973000.0 through Dec 2025, down 16.48% year-over-year, with the annual reading at $973000.0 for FY2025, 16.48% down from the prior year.
- Receivables - Other hit $973000.0 in Q4 2025 for Bolt Biotherapeutics, down from $1.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.5 million in Q4 2023 to a low of $973000.0 in Q4 2025.
- Historically, Receivables - Other has averaged $1.2 million across 3 years, with a median of $1.2 million in 2024.
- Biggest five-year swings in Receivables - Other: dropped 23.71% in 2024 and later fell 16.48% in 2025.
- Year by year, Receivables - Other stood at $1.5 million in 2023, then decreased by 23.71% to $1.2 million in 2024, then dropped by 16.48% to $973000.0 in 2025.
- Business Quant data shows Receivables - Other for BOLT at $973000.0 in Q4 2025, $1.2 million in Q4 2024, and $1.5 million in Q4 2023.